PL2677029T3 - Sposoby wytwarzania poddanych obróbce proteolitycznej polipeptydów - Google Patents

Sposoby wytwarzania poddanych obróbce proteolitycznej polipeptydów

Info

Publication number
PL2677029T3
PL2677029T3 PL13184864T PL13184864T PL2677029T3 PL 2677029 T3 PL2677029 T3 PL 2677029T3 PL 13184864 T PL13184864 T PL 13184864T PL 13184864 T PL13184864 T PL 13184864T PL 2677029 T3 PL2677029 T3 PL 2677029T3
Authority
PL
Poland
Prior art keywords
manufacture
methods
proteolytically processed
processed polypeptides
polypeptides
Prior art date
Application number
PL13184864T
Other languages
English (en)
Inventor
Andreas Rummel
Original Assignee
Ipsen Bioinnovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44453883&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2677029(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ipsen Bioinnovation Ltd filed Critical Ipsen Bioinnovation Ltd
Publication of PL2677029T3 publication Critical patent/PL2677029T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
PL13184864T 2011-05-19 2011-05-19 Sposoby wytwarzania poddanych obróbce proteolitycznej polipeptydów PL2677029T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13184864.0A EP2677029B1 (en) 2011-05-19 2011-05-19 Methods for the manufacture of proteolytically processed polypeptides
EP11004152.2A EP2524963B1 (en) 2011-05-19 2011-05-19 Methods for the manufacture of proteolytically processed polypeptides

Publications (1)

Publication Number Publication Date
PL2677029T3 true PL2677029T3 (pl) 2017-10-31

Family

ID=44453883

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13184864T PL2677029T3 (pl) 2011-05-19 2011-05-19 Sposoby wytwarzania poddanych obróbce proteolitycznej polipeptydów

Country Status (6)

Country Link
EP (3) EP3162894B1 (pl)
DK (1) DK2677029T3 (pl)
ES (2) ES2708661T3 (pl)
HU (1) HUE033172T2 (pl)
PL (1) PL2677029T3 (pl)
PT (1) PT2677029T (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE033172T2 (en) 2011-05-19 2017-11-28 Ipsen Bioinnovation Ltd A method for producing proteolytically processed polypeptides
JP6156954B2 (ja) 2012-11-21 2017-07-05 イプセン バイオイノベーション リミテッド タンパク分解性にプロセシングされたポリペプチドの製造方法
GB201407525D0 (en) * 2014-04-29 2014-06-11 Syntaxin Ltd Manufacture of recombinant clostridium botulinum neurotoxins
MX2018014066A (es) 2016-05-16 2019-04-04 Harvard College Metodo para purificacion y activacion de la neurotoxina botulinica.
EP3263710A1 (en) 2016-07-01 2018-01-03 Ipsen Biopharm Limited Production of activated clostridial neurotoxins
KR102174197B1 (ko) 2019-06-12 2020-11-04 주식회사 앤씨비아이티 생산성이 향상된 비독성 프로테아제
TWI825396B (zh) 2020-03-16 2023-12-11 英商艾普森生物製藥有限公司 肢體痙攣之治療
GB202003813D0 (en) 2020-03-16 2020-04-29 Ipsen Biopharm Ltd Treatment of upper facial lines
AU2022348206A1 (en) 2021-09-16 2024-03-28 Ipsen Biopharm Limited Modified bont/a for use in the treatment of cervical dystonia
GB202113602D0 (en) 2021-09-23 2021-11-10 Ipsen Biopharm Ltd Treatment of a disorder affecting an eyelid muscle of a subject
CA3228712A1 (en) 2021-09-23 2023-03-30 Nicolae GRIGORE Modified bont/a for use in the treatment of a disorder affecting an eyelid muscle of a subject
CA3234608A1 (en) 2021-11-22 2023-05-25 Ipsen Biopharm Limited Treatment of pain
GB202206362D0 (en) 2022-04-29 2022-06-15 Ipsen Biopharm Ltd Treatment of upper facial lines
GB202206361D0 (en) 2022-04-29 2022-06-15 Ipsen Biopharm Ltd Treatment of a facial dystonia
GB202206353D0 (en) 2022-04-29 2022-06-15 Ipsen Biopharm Ltd Treatment of cervical dystonia
GB202206348D0 (en) 2022-04-29 2022-06-15 Ipsen Biopharm Ltd Treatment of limb spasticity
GB202213479D0 (en) 2022-09-14 2022-10-26 Ipsen Biopharm Ltd Cell-free clostridial neurotoxin assays

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2907695A (en) 1994-08-08 1996-03-07 Wisconsin Alumni Research Foundation Purification and pharmaceutical compositions containing type g botulinum neurotoxin
US8012491B2 (en) * 1996-08-23 2011-09-06 Syntaxin, Ltd. Recombinant toxin fragments
DE19856897A1 (de) 1998-12-10 2000-06-15 Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh Therapeutikum zur Unterdrückung von Schnarchgeräuschen
US7402556B2 (en) * 2000-08-24 2008-07-22 Medarex, Inc. Prodrugs activated by plasmin and their use in cancer chemotherapy
US9072735B2 (en) * 2005-10-03 2015-07-07 Yong Qian Proteinases destroy cancer tumor's solid structure and kill cancer cells locally
EP2178905B1 (en) 2007-07-26 2013-11-06 Allergan, Inc. Methods of activiting clostridial toxins
HUE033172T2 (en) 2011-05-19 2017-11-28 Ipsen Bioinnovation Ltd A method for producing proteolytically processed polypeptides

Also Published As

Publication number Publication date
EP2524963B1 (en) 2018-10-31
EP2677029A3 (en) 2014-06-11
DK2677029T3 (da) 2017-08-07
EP2677029A2 (en) 2013-12-25
EP2524963A1 (en) 2012-11-21
PT2677029T (pt) 2017-08-11
HUE033172T2 (en) 2017-11-28
ES2634261T3 (es) 2017-09-27
EP3162894A2 (en) 2017-05-03
EP3162894A3 (en) 2017-08-09
EP3162894B1 (en) 2024-01-10
EP2677029B1 (en) 2017-05-10
ES2708661T3 (es) 2019-04-10

Similar Documents

Publication Publication Date Title
HK1210191A1 (en) Methods for the manufacture of proteolytically processed polypeptides
PL2677029T3 (pl) Sposoby wytwarzania poddanych obróbce proteolitycznej polipeptydów
HRP20160665T1 (hr) Postupak proizvodnje ternesit klinkera
IL222454B (en) A process for the production of recombinant polypeptides
HK1199882A1 (zh) 用於製備雌四醇的方法
EP2552874A4 (en) PROCESS FOR PREPARING HEXAFLUOR-2 BUTENE
ZA201305972B (en) Method for the preparation of biphephos
HRP20181747T1 (hr) Postupak za selektivnu proizvodnju n-metil-para-anisidina
IL222453B (en) A process for the production of recombinant polypeptides
EP2558432A4 (en) METHOD FOR THE PRODUCTION OF TETRAFLUOROLEFINES
EP2772546A4 (en) PROCESS FOR PRODUCTION OF SECRETION FOR A PROTEIN
SG11201400939YA (en) Process for the preparation of methoxymelonal
HK1204667A1 (en) Method for the production of solid surfaces for construction
SG11201400405TA (en) Caninised antibodies and method for the production of same
PL2625262T3 (pl) Sposób wytwarzania białka
EP2653540A4 (en) PROTEIN PRODUCTION PROCESS
LT2696959T (lt) Aplinkai nekenksmingas cemento gamybos būdas
HUP1200171A1 (hu) Módszerek polipeptidek elõállítására
HK1210225A1 (en) Procedure for the production of tiacumicin
HUE044066T2 (hu) Eljárás metilén-difenil-diizocianát elõállítására
EP2737065A4 (en) PROCESS FOR PRODUCING PROTEINS
ZA201303361B (en) Process for extrusing particles
HK1197229A1 (en) Process for the preparation of protease inhibitors
PL2934428T3 (pl) Sposób zwiększania wytrzymałości ceramik
PL394420A1 (pl) Sposób wytwarzania dilauroilofluoresceiny